Income statement, balance sheet and cash flow statement for the last 3 fiscal years, taken from the XBRL data Omada Health, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2023
FY2025
FY2025
Revenue
123
170
260
Cost of revenue
52.8
66.9
89.3
Gross profit
70
103
171
Research and development
33.7
35.9
40.7
Selling and marketing
66.2
68.1
90
General and administrative
36
42.6
52.2
Operating expenses
136
147
183
Operating income
-66
-43.7
-12
Interest expense
4.71
4.51
2.53
Interest income
5.78
0.81
5.31
Other non-operating income
-1.51
-3.48
-0.81
Pre-tax income
-67.5
-47.1
-12.8
Income tax
0
0
0
Net income
-67.5
-47.1
-12.8
EBITDA
-61.5
-38.9
-6.48
EPS, basic
-9.52
-6.11
-0.35
EPS, diluted
-9.52
-6.11
-0.35
Shares, basic (weighted)
7.09
7.72
36.6
Shares, diluted (weighted)
7.09
7.72
36.6
Balance sheet
FY2023
FY2025
FY2025
Cash and equivalents
116
76.4
222
Receivables
23.4
34.6
Inventory
3.3
4.49
Other current assets
2.14
1.89
Total current assets
113
273
Property, plant and equipment
5.63
7.94
Lease right-of-use assets
0.45
0
Goodwill
13.2
13.2
Intangible assets
4.26
2.41
Other non-current assets
5.04
0.17
Total assets
151
305
Accounts payable
4.17
10.3
Accrued liabilities
29.8
40.4
Deferred revenue
19.5
25.1
Total current liabilities
54
75.7
Other non-current liabilities
0.29
0
Total liabilities
86.3
75.7
Total debt
29.8
0
Paid-in capital
59.6
686
Retained earnings
-444
-457
Shareholders' equity
-350
-384
230
Total equity
-350
-384
230
Total liabilities and equity
151
305
Shares outstanding
8.16
58.4
Cash flow statement
FY2023
FY2025
FY2025
Net income
-67.5
-47.1
-12.8
Depreciation and amortization
4.45
4.8
5.49
Stock-based compensation
8.74
9.42
13
Change in receivables
-5.34
-8.81
-12.4
Change in inventory
-0.07
0.32
-1.19
Change in payables
-0.29
0.4
6.29
Cash from operations
-49.7
-34.2
18.3
Capital expenditures
-0.42
-0.6
-1.32
Cash from investing
-2.92
-3.86
-5.83
Stock issued
1.76
3.33
9.37
Cash from financing
0.18
-1.21
133
Net change in cash
-52.5
-39.3
146
Free cash flow
-50.2
-34.8
16.9
Interest paid
4.1
3.85
2.42
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2026; growth uses fiscal years. Valuation uses the share price of $14.85 on November 10, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
70.7%
Gross profit / revenue.
Operating margin
2.1%
Operating income / revenue.
EBITDA margin
3.9%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
4.2%
Pre-tax income / revenue.
Net margin
4.2%
Net income / revenue.
FCF margin
8.5%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
8.6%
Cash from operations / revenue.
Effective tax rate
0.0%
Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)
5.1%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
4.0%
Net income / average total assets.
Return on invested capital (ROIC)
22.9%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
16.3%
Research and development expense / revenue.
Stock-based pay / revenue
5.8%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.2%
Capital expenditures / revenue.
D&A / revenue
1.9%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
53.2%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
66.2%
Gross profit vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
102.4%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
374.5%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
4.18x
Current assets / current liabilities.
Quick ratio
3.87x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
3.23x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
FCF conversion
200.6%
Free cash flow / net income, when net income is positive.
Capex / operating cash flow
1.9%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
$0.21
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$4.96
Revenue / diluted weighted shares.
FCF per share
$0.42
Free cash flow / diluted weighted shares.
Operating cash flow per share
$0.43
Cash from operations / diluted weighted shares.
Book value per share
$4.41
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/E
64.8x
Market cap / net income. Only when net income is positive.
P/S
2.73x
Market cap / revenue.
P/B
3.33x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
3.51x
Market cap / tangible book value, when positive.
P/FCF
32.3x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
31.7x
Market cap / cash from operations, when positive.
EV/Sales
2.00x
Enterprise value / revenue.
EV/EBIT
96.9x
Enterprise value / operating income, when both are positive.
EV/EBITDA
50.9x
Enterprise value / EBITDA, when both are positive.
EV/FCF
23.7x
Enterprise value / free cash flow, when both are positive.
FCF yield
3.1%
Free cash flow / market cap.
Earnings yield
1.5%
Net income / market cap (the inverse of P/E).
What was Omada Health, Inc.'s revenue in fiscal 2025?
Omada Health, Inc. reported revenue of $260.2M for fiscal 2025, 53.2% higher than the year before.
Was Omada Health, Inc. profitable in fiscal 2025?
No. It reported a net loss of $12.8M.
How much free cash flow did Omada Health, Inc. generate in fiscal 2025?
Cash from operations of $18.3M minus capital expenditures of $1.3M left free cash flow of $16.9M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.